Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

Ítems similars

• Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
  per: Valmori, D, et al.
  Publicat: (1999)
• Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
  per: Valmori, D, et al.
  Publicat: (1999)
• Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
  per: Romero, P, et al.
  Publicat: (1998)
• An antigen-targeted approach to adoptive transfer therapy of cancer.
  per: Valmori, D, et al.
  Publicat: (1999)
• Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
  per: Youde, S, et al.
  Publicat: (2000)